NCT01714102View on ClinicalTrials.gov

Resveratrol and the Metabolic Syndrome

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

August 31, 2015

Study Completion Date

July 31, 2018

Conditions
ObesityInsulin ResistanceMetabolic Syndrome
Interventions
DIETARY_SUPPLEMENT

Placebo

Placebo manufactured to mimic resveratrol tablet

DIETARY_SUPPLEMENT

Resveratrol

Resveratrol PO BID for 30 days

Trial Locations (1)

10065

The Rockefeller University, New York

All Listed Sponsors
lead

Rockefeller University

OTHER

NCT01714102 - Resveratrol and the Metabolic Syndrome | Biotech Hunter | Biotech Hunter